JC
JBF Capital, Inc.
13F filer · CIK 0001483864Reported Aug 13, 2026
Net seller this quarter
13F portfolio value$764MU.S. long equity reported on 13F
Positions8917 new · 30 closed
Net flow last quarter-$43.3MBuys minus sells
Top 10 positions weight36.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 13, 202689 positions | |||||
| $64.8M | 8.49% | 0.00% | Not reported | Q3 2015 | |
| $63.3M | 8.29% | 0.00% | Not reported | Q1 2014 | |
| $35.7M | 4.68% | 0.00% | Not reported | Q4 2021 | |
| $34.9M | 4.57% | 1.01% | Not reported | Q3 2021 | |
| $20.9M | 2.74% | 0.01% | +300.0% | Q2 2013 | |
| $17.3M | 2.26% | 0.01% | +33.3% | Q3 2020 | |
| $11.5M | 1.51% | Not reported | Not reported | Q1 2017 | |
| $9.82M | 1.29% | 0.00% | +500.0% | Q2 2013 | |
| $8.56M | 1.12% | 0.01% | Not reported | Q1 2021 | |
| $7.93M | 1.04% | 0.01% | Not reported | Q1 2024 | |
| $6.8M | 0.89% | 0.00% | Not reported | Q3 2023 | |
| $5.97M | 0.78% | 0.00% | Not reported | Q4 2025 | |
| $5.24M | 0.69% | 0.00% | Not reported | Q4 2024 | |
| $3.82M | 0.50% | 0.01% | +100.0% | Q1 2023 | |
| $3.62M | 0.47% | 0.05% | -35.5% | Q2 2023 | |
| $3.6M | 0.47% | 0.00% | Not reported | Q1 2026 | |
| $3.3M | 0.43% | 0.00% | Not reported | Q1 2020 | |
| $3.12M | 0.41% | 0.01% | Not reported | Q4 2025 | |
| $3.03M | 0.40% | Not reported | +42.7% | Q1 2014 | |
| $2.75M | 0.36% | 0.62% | -66.0% | Q4 2025 | |
| $2.41M | 0.31% | 0.01% | -10.8% | Q4 2018 | |
| $2.32M | 0.30% | 0.00% | Not reported | Q1 2026 | |
| $2.21M | 0.29% | 0.01% | Not reported | Q3 2022 | |
| $1.78M | 0.23% | 0.00% | New | Q2 2026 | |
| $1.75M | 0.23% | 0.03% | +92.2% | Q1 2026 | |
| $1.67M | 0.22% | 0.22% | New | Q2 2026 | |
| $1.66M | 0.22% | 0.00% | Not reported | Q2 2013 | |
| $1.61M | 0.21% | 0.00% | Not reported | Q4 2023 | |
| $1.52M | 0.20% | 0.01% | +180.0% | Q3 2025 | |
| $1.49M | 0.20% | 0.00% | Not reported | Q2 2013 | |
| $1.37M | 0.18% | 0.00% | Not reported | Q1 2020 | |
| $1.27M | 0.17% | 0.03% | Not reported | Q3 2021 | |
| $1.14M | 0.15% | 0.01% | New | Q2 2026 | |
| $1.11M | 0.15% | 0.84% | +67.2% | Q3 2025 | |
| $1.09M | 0.14% | 0.01% | Not reported | Q1 2026 | |
| $1.05M | 0.14% | 0.01% | Not reported | Q2 2023 | |
| $962K | 0.13% | 0.00% | Not reported | Q3 2018 | |
| $934K | 0.12% | 0.02% | -5.3% | Q3 2020 | |
| $904K | 0.12% | Not reported | New | Q2 2026 | |
| $903K | 0.12% | 0.00% | Not reported | Q3 2019 | |
| ETESPREsperion Therapeutics, Inc. | $898K | 0.12% | 0.11% | New | Q2 2026 |
| $873K | 0.11% | 0.11% | New | Q2 2026 | |
| $762K | 0.10% | 0.06% | Not reported | Q3 2019 | |
| $711K | 0.09% | 0.00% | New | Q2 2026 | |
| $650K | 0.09% | 0.02% | Not reported | Q3 2020 | |
| $585K | 0.08% | 0.43% | Not reported | Q4 2025 | |
| $566K | 0.07% | 0.00% | New | Q2 2026 | |
| $512K | 0.07% | 0.00% | -30.0% | Q4 2021 | |
| $492K | 0.06% | 0.02% | Not reported | Q1 2026 | |
| $477K | 0.06% | 0.00% | -20.0% | Q1 2026 | |
| Q1 2026Reported May 8, 2026102 positions | |||||
| $62.8M | 9.29% | 0.00% | Not reported | Q1 2014 | |
| $56.6M | 8.37% | 0.00% | Not reported | Q3 2015 | |
| $28.8M | 4.25% | 0.00% | Not reported | Q4 2021 | |
| $28.1M | 4.16% | 1.01% | Not reported | Q3 2021 | |
| $16.9M | 2.50% | 0.01% | Not reported | Q2 2013 | |
| $11.7M | 1.73% | Not reported | Not reported | Q1 2017 | |
| $9.62M | 1.42% | 0.00% | +44.9% | Q4 2023 | |
| $9.17M | 1.36% | 0.01% | Not reported | Q1 2021 | |
| $6.51M | 0.96% | 1.83% | Not reported | Q4 2025 | |
| $5.93M | 0.88% | 0.00% | -30.6% | Q3 2023 | |
| $5.84M | 0.86% | Not reported | -8.5% | Q1 2024 | |
| $5.52M | 0.82% | 0.00% | Not reported | Q4 2024 | |
| $5.51M | 0.81% | 0.00% | Not reported | Q3 2023 | |
| $5.1M | 0.75% | 0.01% | Not reported | Q1 2024 | |
| $4.92M | 0.73% | 0.00% | Not reported | Q3 2020 | |
| $4.11M | 0.61% | 0.00% | Not reported | Q2 2013 | |
| $3.96M | 0.59% | 0.00% | Not reported | Q4 2025 | |
| $3.86M | 0.57% | 0.01% | Not reported | Q4 2025 | |
| $3.43M | 0.51% | Not reported | -42.2% | Q1 2014 | |
| $3.38M | 0.50% | 0.00% | Not reported | Q2 2022 | |
| $3.08M | 0.46% | 0.00% | Not reported | Q1 2020 | |
| $2.82M | 0.42% | 0.08% | Not reported | Q2 2023 | |
| $2.76M | 0.41% | 0.00% | New | Q1 2026 | |
| DHDHILDiamond Hill Investment Group Inc | $2.65M | 0.39% | 0.57% | Not reported | Q3 2015 |
| $2.57M | 0.38% | 0.00% | New | Q1 2026 | |
| $2.54M | 0.38% | 0.01% | -5.1% | Q4 2018 | |
| $2.03M | 0.30% | 0.00% | New | Q1 2026 | |
| $1.97M | 0.29% | 0.01% | +50.3% | Q3 2022 | |
| $1.93M | 0.29% | 0.00% | +233.3% | Q1 2023 | |
| $1.58M | 0.23% | 0.00% | Not reported | Q4 2023 | |
| $1.51M | 0.22% | 0.00% | New | Q1 2026 | |
| $1.5M | 0.22% | 0.03% | Not reported | Q1 2019 | |
| $1.47M | 0.22% | 0.00% | Not reported | Q2 2013 | |
| $1.22M | 0.18% | 0.03% | Not reported | Q3 2021 | |
| $1.17M | 0.17% | 0.01% | Not reported | Q4 2022 | |
| $1.11M | 0.16% | 0.01% | Not reported | Q2 2023 | |
| $1.1M | 0.16% | 0.00% | Not reported | Q1 2024 | |
| $1.03M | 0.15% | 0.01% | New | Q1 2026 | |
| $1M | 0.15% | 0.00% | Not reported | Q4 2014 | |
| $1M | 0.15% | 0.01% | New | Q1 2026 | |
| $980K | 0.14% | Not reported | New | Q1 2026 | |
| $964K | 0.14% | 0.00% | Not reported | Q1 2018 | |
| $962K | 0.14% | 0.00% | Not reported | Q3 2018 | |
| $938K | 0.14% | 0.00% | -19.4% | Q4 2021 | |
| $902K | 0.13% | 0.50% | +1021.3% | Q3 2025 | |
| CPCNTACentessa Pharmaceuticals PLC | $830K | 0.12% | 0.01% | New | Q1 2026 |
| APAPLSApellis Pharmaceuticals, Inc. | $826K | 0.12% | 0.02% | New | Q1 2026 |
| $821K | 0.12% | 0.00% | +28.6% | Q3 2019 | |
| $814K | 0.12% | 0.02% | +123.5% | Q3 2020 | |
| HHOLXHologic Inc | $808K | 0.12% | 0.00% | New | Q1 2026 |
| Q4 2025Reported Feb 12, 202668 positions | |||||
| $82.1M | 11.85% | 0.00% | -5.2% | Q1 2014 | |
| $62.8M | 9.06% | 0.00% | Not reported | Q3 2015 | |
| $31.3M | 4.52% | 0.00% | Not reported | Q4 2021 | |
| $27.4M | 3.95% | 1.01% | Not reported | Q3 2021 | |
| $22.1M | 3.19% | Not reported | -21.7% | Q2 2025 | |
| $13.5M | 1.95% | Not reported | -32.8% | Q1 2017 | |
| $9.36M | 1.35% | 0.01% | Not reported | Q1 2021 | |
| $9.14M | 1.32% | 0.00% | Not reported | Q3 2023 | |
| $6.47M | 0.93% | 0.00% | -12.7% | Q4 2023 | |
| $6.16M | 0.89% | 0.00% | -1.1% | Q3 2023 | |
| $6.14M | 0.89% | 1.83% | New | Q4 2025 | |
| $5.67M | 0.82% | 0.01% | Not reported | Q1 2024 | |
| $5.16M | 0.74% | Not reported | Not reported | Q1 2024 | |
| $4.9M | 0.71% | 0.00% | Not reported | Q4 2024 | |
| $4.39M | 0.63% | Not reported | +53.7% | Q1 2014 | |
| $3.86M | 0.56% | 0.01% | New | Q4 2025 | |
| $3.22M | 0.47% | 0.00% | Not reported | Q1 2020 | |
| $3.21M | 0.46% | 0.00% | New | Q4 2025 | |
| $2.85M | 0.41% | 0.00% | Not reported | Q2 2022 | |
| $2.8M | 0.40% | 0.01% | -2.5% | Q4 2018 | |
| $2.7M | 0.39% | 0.08% | -12.9% | Q2 2023 | |
| DHDHILDiamond Hill Investment Group Inc | $2.61M | 0.38% | 0.57% | Not reported | Q3 2015 |
| $2.49M | 0.36% | 0.00% | New | Q4 2025 | |
| $1.87M | 0.27% | 0.00% | Not reported | Q4 2023 | |
| $1.61M | 0.23% | 0.00% | Not reported | Q2 2013 | |
| $1.61M | 0.23% | 0.01% | +7.2% | Q3 2022 | |
| $1.25M | 0.18% | 0.01% | Not reported | Q2 2023 | |
| $1.18M | 0.17% | 0.02% | Not reported | Q3 2021 | |
| $870K | 0.13% | 0.02% | Not reported | Q4 2021 | |
| APAVDLAvadel Pharmaceuticals PLC | $862K | 0.12% | 0.04% | New | Q4 2025 |
| $848K | 0.12% | 0.00% | Not reported | Q3 2019 | |
| $831K | 0.12% | 0.22% | Not reported | Q4 2023 | |
| $815K | 0.12% | 0.01% | Not reported | Q4 2022 | |
| $749K | 0.11% | 0.05% | Not reported | Q3 2019 | |
| $699K | 0.10% | 0.00% | +3.3% | Q4 2021 | |
| $696K | 0.10% | 0.05% | Not reported | Q3 2025 | |
| $641K | 0.09% | 0.00% | -36.8% | Q3 2019 | |
| $580K | 0.08% | 0.48% | New | Q4 2025 | |
| $495K | 0.07% | 0.00% | Not reported | Q1 2023 | |
| $473K | 0.07% | 0.00% | Not reported | Q1 2019 | |
| $460K | 0.07% | 0.01% | +21.4% | Q3 2020 | |
| $459K | 0.07% | Not reported | New | Q4 2025 | |
| $444K | 0.06% | 0.01% | +20.0% | Q3 2020 | |
| $433K | 0.06% | 0.00% | +60.0% | Q3 2025 | |
| $412K | 0.06% | 0.00% | -16.7% | Q3 2025 | |
| $407K | 0.06% | 0.00% | Not reported | Q4 2013 | |
| $324K | 0.05% | 0.11% | Not reported | Q3 2019 | |
| IBIROQIF Bancorp, Inc. | $324K | 0.05% | 0.36% | New | Q4 2025 |
| $322K | 0.05% | 0.34% | New | Q4 2025 | |
| $297K | 0.04% | 0.00% | Not reported | Q3 2020 | |
| Q3 2025Reported Nov 14, 202568 positions | |||||
| $92.7M | 13.14% | 0.00% | Not reported | Q1 2014 | |
| $59.7M | 8.46% | 0.00% | Not reported | Q3 2015 | |
| $32.2M | 4.57% | 1.00% | Not reported | Q3 2021 | |
| $27.6M | 3.91% | Not reported | Not reported | Q2 2025 | |
| $24.3M | 3.45% | 0.00% | +334.8% | Q4 2021 | |
| $22.4M | 3.17% | Not reported | +48.8% | Q1 2017 | |
| $16.8M | 2.38% | 0.01% | Not reported | Q2 2025 | |
| $9.75M | 1.38% | 0.01% | Not reported | Q1 2021 | |
| $9.47M | 1.34% | 0.00% | Not reported | Q4 2023 | |
| $9.14M | 1.30% | 0.00% | Not reported | Q3 2023 | |
| $6.68M | 0.95% | 0.01% | Not reported | Q1 2024 | |
| $5.94M | 0.84% | 0.00% | Not reported | Q3 2023 | |
| $4.68M | 0.66% | 0.00% | +10.0% | Q3 2020 | |
| $4.68M | 0.66% | 0.00% | Not reported | Q4 2024 | |
| $4.34M | 0.62% | Not reported | Not reported | Q1 2024 | |
| $4.32M | 0.61% | 0.00% | Not reported | Q4 2024 | |
| $3.79M | 0.54% | 0.00% | Not reported | Q1 2020 | |
| $3.58M | 0.51% | Not reported | Not reported | Q1 2014 | |
| $2.95M | 0.42% | 0.00% | Not reported | Q4 2024 | |
| $2.42M | 0.34% | 0.09% | Not reported | Q2 2023 | |
| $2.42M | 0.34% | 0.01% | -7.0% | Q4 2018 | |
| DHDHILDiamond Hill Investment Group Inc | $2.15M | 0.31% | 0.57% | Not reported | Q3 2015 |
| $1.8M | 0.25% | 0.00% | Not reported | Q4 2023 | |
| $1.67M | 0.24% | 0.00% | Not reported | Q2 2022 | |
| $1.58M | 0.22% | 0.00% | Not reported | Q2 2013 | |
| $1.38M | 0.20% | 0.02% | Not reported | Q4 2021 | |
| $1.28M | 0.18% | 0.01% | -5.3% | Q3 2022 | |
| $1.13M | 0.16% | 0.01% | Not reported | Q2 2023 | |
| $1.1M | 0.16% | 0.02% | Not reported | Q3 2021 | |
| $1.1M | 0.16% | 0.24% | New | Q3 2025 | |
| $1.08M | 0.15% | 0.19% | New | Q3 2025 | |
| $1.05M | 0.15% | 0.10% | New | Q3 2025 | |
| $1.04M | 0.15% | 0.06% | New | Q3 2025 | |
| $1M | 0.14% | 0.00% | Not reported | Q2 2016 | |
| $1M | 0.14% | 0.20% | New | Q3 2025 | |
| $956K | 0.14% | 0.22% | Not reported | Q4 2023 | |
| $956K | 0.14% | Not reported | New | Q3 2025 | |
| $837K | 0.12% | 0.00% | -10.3% | Q3 2019 | |
| $776K | 0.11% | 0.01% | Not reported | Q4 2022 | |
| SSCPHScpharmaceuticals Inc. | $765K | 0.11% | 0.25% | New | Q3 2025 |
| $763K | 0.11% | 0.18% | Not reported | Q1 2025 | |
| $744K | 0.11% | 0.00% | -12.5% | Q3 2019 | |
| 8ETNB89bio, Inc. | $735K | 0.10% | 0.03% | New | Q3 2025 |
| $709K | 0.10% | 0.00% | +20.0% | Q4 2021 | |
| $674K | 0.10% | 0.05% | New | Q3 2025 | |
| $515K | 0.07% | 0.00% | Not reported | Q1 2023 | |
| $496K | 0.07% | 0.05% | Not reported | Q3 2019 | |
| $456K | 0.06% | 0.00% | -8.3% | Q1 2019 | |
| $428K | 0.06% | 0.00% | New | Q3 2025 | |
| $414K | 0.06% | 0.00% | New | Q3 2025 | |
Premium opens every quarter this fund has filed